chr19-3976601-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001961.4(EEF2):c.2530C>T(p.Leu844=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00074 in 1,610,816 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00042 ( 3 hom. )
Consequence
EEF2
NM_001961.4 synonymous
NM_001961.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.43
Genes affected
EEF2 (HGNC:3214): (eukaryotic translation elongation factor 2) This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 19-3976601-G-A is Benign according to our data. Variant chr19-3976601-G-A is described in ClinVar as [Benign]. Clinvar id is 447301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.43 with no splicing effect.
BS2
High AC in GnomAd4 at 574 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EEF2 | NM_001961.4 | c.2530C>T | p.Leu844= | synonymous_variant | 15/15 | ENST00000309311.7 | NP_001952.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EEF2 | ENST00000309311.7 | c.2530C>T | p.Leu844= | synonymous_variant | 15/15 | 5 | NM_001961.4 | ENSP00000307940 | P1 | |
EEF2 | ENST00000600794.1 | c.108-301C>T | intron_variant | 3 | ENSP00000471265 |
Frequencies
GnomAD3 genomes AF: 0.00374 AC: 569AN: 152208Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
569
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000884 AC: 214AN: 242160Hom.: 0 AF XY: 0.000646 AC XY: 85AN XY: 131588
GnomAD3 exomes
AF:
AC:
214
AN:
242160
Hom.:
AF XY:
AC XY:
85
AN XY:
131588
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000424 AC: 618AN: 1458490Hom.: 3 Cov.: 31 AF XY: 0.000389 AC XY: 282AN XY: 725304
GnomAD4 exome
AF:
AC:
618
AN:
1458490
Hom.:
Cov.:
31
AF XY:
AC XY:
282
AN XY:
725304
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00377 AC: 574AN: 152326Hom.: 2 Cov.: 32 AF XY: 0.00352 AC XY: 262AN XY: 74490
GnomAD4 genome
AF:
AC:
574
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
262
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 14, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at